1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Novartis IT


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    9
    Views:
    1,894
  2. anonymous
    Replies:
    1
    Views:
    716
  3. anonymous
    Replies:
    6
    Views:
    1,608
  4. anonymous
    Replies:
    23
    Views:
    6,481
  5. anonymous
    Replies:
    2
    Views:
    1,657
  6. anonymous
    Replies:
    3
    Views:
    2,790
  7. Anonymous
    Replies:
    12
    Views:
    6,774
  8. anonymous
    Replies:
    1
    Views:
    2,518
  9. anonymous
    Replies:
    0
    Views:
    2,190
  10. anonymous
    Replies:
    5
    Views:
    3,842
  11. anonymous
    Replies:
    26
    Views:
    13,670
  12. anonymous
    Replies:
    6
    Views:
    3,245
  13. Anonymous
    Replies:
    25
    Views:
    24,816
  14. anonymous
    Replies:
    4
    Views:
    5,077
  15. anonymous
    Replies:
    2
    Views:
    3,315
  16. Anonymous
    Replies:
    22
    Views:
    11,508
  17. anonymous
    Replies:
    0
    Views:
    2,107
  18. Anonymous
    Replies:
    15
    Views:
    7,178
  19. Anonymous
    Replies:
    1
    Views:
    2,268
  20. Anonymous
    Replies:
    1
    Views:
    2,600

Thread Display Options

Loading...